New device combines laser atherectomy and intravascular lithotripsy for the treatment of PAD
A look around the industry at some of the newest solutions entering the market
Program emphasizes imaging informatics strategies for developing best practices
Researchers get $12.7 million NIH grant.
Findings may impact therapy choices for other pelvic malignancies too
Here's what to expect for the show in February.
Acquired in 2019 for $1.1 billion
Initiative to focus on three types of imaging procedures with high radiation doses.
Could improve outcomes with 'minimal investment' needed from clinicians
Federal officials fund the development of six anti-radiation drugs.
C-RAD appoints interim CFO
Early-stage transcatheter mitral valve replacement company
The state's first proton therapy center will treat about 1,500 patients annually.
Bringing SubtlePET efficiency to Illuccix prostate PET scans
Acceletronics Digital Imaging, LLC announces it has received 510(K) marketing clearance from the US Food and Drug Administration (FDA) for the new RAD II KV Imager for Image Guided Radiation Therapy (IGRT). The RAD II KV Imager can be mounted on virtually any model of linear accelerator.
Cleveland BioLabs just got a patent for a drug that could protect people from radiation sickness, possibly saving lives in the aftermath of a nuclear power plant accident or radioactive "dirty" bomb attack.
TJC urges doctors use X-rays with "great care."
Leader in Proton Therapy Applies Expertise Towards New Technologies in Cancer Treatment.
Already producing Cu-67, with plans to add Ac-225 later this year
Insights from Dr. Laura Crocitto, vice president and chief medical officer of cancer services in the Helen Diller Family Comprehensive Cancer Center at UCSF
Biotechs Apogee, Avaxia net grants.
Also on display will be Varian's software products for planning and managing radiation therapy treatments, as well as the latest technology for filmless X-ray imaging.
Making 'difficult' short-term decisions to benefit long term
May be better at detecting subtle abnormalities indicative of early-stage fibrosis
Construction firm gets Saudi proton contract.
The company anticipates movement in the FDA in three years.
